News Articles

Penn study uncovers secrets of a clump-dissolving protein

1/26/15 - Implications for new therapies for brain disorders involving misfolded proteins.

UCSD study shows why protein mutations lead to familial form of Parkinson's disease

1/26/15 - Researchers at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego, have shown for the first time why protein mutations lead to the familial form of Parkinson's...

Strategy to reduce stigma of facial paralysis

1/23/15 - A little bit of sensitivity training can help people form better first impressions of those with facial paralysis, reducing prejudices against people with a visible but often unrecognizable...

Portable stimulator being tested on Parkinson patients

1/22/15 - Researchers at the University of Gothenburg have shown that a weak electric "noise" can improve balance and motor skills in patients with Parkinson's disease.

Testing of portable stimulator on Parkinson's patients

1/21/15 - Parkinson's disease is a slowly degenerative neurological disease that is expressed as impaired motor control, tremors, stiffness and, in later stages, problems with balance.

Animal model finds extra-short nanowires best for brain

1/19/15 - If in the future electrodes are inserted into the human brain - either for research purposes or to treat diseases - it may be appropriate to give them a 'coat' of nanowires that could make them less...

C. elegans study reveals that excess iron promotes aging

1/19/15 - It's been known for decades that some metals, including iron, accumulate in human tissues during aging and that toxic levels of iron have been linked to neurologic diseases, such as Parkinson's.

Newron announces results of Phase I study of NW-3509, Phase II study in schizophrenia patients planned for Q2 2015

1/16/15 - Newron Pharmaceuticals S.p.A., a research and development company focused on novel CNS and pain therapies, has announced the completion of the first in man US Phase I study of its novel sodium...

Possible new target discovered for treating brain inflammation

1/14/15 - A team led by scientists at The Scripps Research Institute (TSRI) has identified an enzyme that produces a class of inflammatory lipid molecules in the brain.

How animals select actions with rewarding outcomes explained by computer model

1/8/15 - The model could provide new insights into the mechanisms behind motor disorders such as Parkinson's Disease. It may also shed light on conditions involving abnormal learning, such as addiction.

NeuroDerm Parkinson's drug shows promise in mid-stage study

1/5/15 - NeuroDerm Ltd., a clinical-stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, has announced that continuous, subcutaneous delivery of the company's proprietary...

Exercise may improve balance, mobility and quality of life in people with Parkinson's

1/1/15 - People with Parkinson's had better balance, movement and quality of life after taking part in three 40-60 minute exercise sessions a week for 6 months, a new study found.

Parkinson's: small molecules researched for the regeneration of dopaminergic neurons

12/28/14 - Researchers in the University of Helsinki plan to develop orally administrable small molecules that act similarly to neurotrophic factor GDNF.

The cause of prostate cancer may be linked to Parkinson's disease through a common enzyme

12/27/14 - Prostate cancer affects more than 23,000 men this year in the USA however the individual genes that initiate prostate cancer formation are poorly understood.

Parkinson's disease reverted at a experimental stage

12/24/14 - Mexican scientists demonstrated experimentally, with adult rats, that mobility can be restored in patients with Parkinson's disease, the major degenerative disease of the motor system worldwide.

Parkinson's patients identify balance and anxiety treatments among top ten research priorities

12/20/14 - Patients with Parkinson's, medics and carers have identified the top ten priorities for research into the management of the condition in a study by the University of East Anglia and Parkinson's UK.

Researchers uncover a mechanism regulating dopamine levels in the brain

12/18/14 - Researchers in Montreal led by Jacques Drouin, D.Sc., uncovered a mechanism regulating dopamine levels in the brain by working on a mouse model of late onset Parkinson's disease.

Meth users 'three times more likely' to develop Parkinson's

12/17/14 - A new study supports findings from previous research that meth users are at increased risk for Parkinson's, but it also finds that female users are at particularly high risk.

Hard-to-reach cancers targeted with 'Trojan horse' proteins

12/17/14 - Scientists at Brunel University London have found a way of targeting hard-to-reach cancers and degenerative diseases using nanoparticles, but without causing the damaging side effects the treatment...

Identifying early signs of cognitive decline which are already present in some individuals during midlife

12/16/14 - Signs of cognitive decline related to aging populations, and even the severe cognitive losses seen in Alzheimer's disease and neurodegenerative disorders, may emerge many years earlier, according to...

Yeast are first cells known to cure themselves of prions

12/14/14 - Yeast cells can sometimes reverse the protein misfolding and clumping associated with diseases such as Alzheimer's, according to new research from the University of Arizona.

Study links Parkinson's disease to gut bacteria

12/12/14 - A new study finds that people with Parkinson's disease have a different mix of gut bacteria to healthy counterparts, suggesting this might be useful for diagnosis or treatment.

A dopamine precursor in the toxic fruits of the morinda tree increases fertility in female Drosophila sechellia flies

12/12/14 - In the course of evolution, animals have become adapted to certain food sources, sometimes even to plants or to fruits that are actually toxic.

Parkinson's vaccine tested on first patients

12/10/14 - A novel Parkinson's vaccine will now be tested in a clinical Phase I trial in Austria by an EU-funded consortium.

Parkinson's drugs likely safe for the heart, larger studies needed

12/8/14 - Non-ergot derived dopamine agonists used to treat Parkinson's disease may be safe for the heart, according to preliminary research presented at EuroEcho-Imaging 2014 by Dr Hilal Erken Pamukcu...